{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:09:46Z","timestamp":1792696186677,"version":"4.5.0"},"reference-count":110,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/14756366.2025.2598741","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:23:34Z","timestamp":1767374614000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["From bench to brain: novel thieno-oxazine hybrids as potent pleiotropic anti-Alzheimer\u2019s agents with\n                    <i>in vivo<\/i>\n                    \/\n                    <i>in vitro<\/i>\n                    validation and\n                    <i>in silico<\/i>\n                    insights"],"prefix":"10.1080","volume":"41","author":[{"given":"Eman A.","family":"Fayed","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Girls), Al-Azhar University","place":["Cairo, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazin","family":"A. A. Najm","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Mazaya University College","place":["Nasiriyah, Iraq"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khulood H.","family":"Oudah","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Mazaya University College","place":["Nasiriyah, Iraq"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha A.","family":"Ebrahim","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Girls), Al-Azhar University","place":["Cairo, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirvana A.","family":"Gohar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Modern University for Technology and Information (MTI)","place":["Cairo, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karema","family":"Abu-Elfotuh","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy (Girls), Al-Azhar University","place":["Cairo, Egypt"]},{"name":"College of Pharmacy, Al-Ayen Iraqi University","place":["Iraq"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Khedre Mohamed","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Egyptian Drug Authority (EDA), formerly National Organization of Drug Control and Research (NODCAR)","place":["Giza, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M. E.","family":"Hamdan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Tabuk","place":["Tabuk, Saudi Arabia"]},{"name":"Prince Fahad Bin Sultan Chair for Biomedical Research (PFSCBR), University of Tabuk","place":["Tabuk, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najla A.","family":"Albalawi","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Tabuk","place":["Tabuk, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahad","family":"Faisal Alzahrani","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Tabuk","place":["Tabuk, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira M.","family":"Hamdan","sequence":"additional","affiliation":[{"name":"Oceanography Department, Faculty of Science, Alexandria University","place":["Alexandria, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reema","family":"Almotairi","sequence":"additional","affiliation":[{"name":"Prince Fahad Bin Sultan Chair for Biomedical Research (PFSCBR), University of Tabuk","place":["Tabuk, Saudi Arabia"]},{"name":"Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk","place":["Tabuk, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaimaa M.","family":"Hafez","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Embryology, Faculty of Medicine, Al-Azhar University","place":["Cairo, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Triveena M.","family":"Ramsis","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Sinai University","place":["Ismailia, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4103\/1673-5374.320970","article-title":"Pathological mechanisms and therapeutic strategies for Alzheimer\u2019s disease","volume":"17","author":"Ju Y","year":"2022","unstructured":"Ju Y, Tam KY. Pathological mechanisms and therapeutic strategies for Alzheimer\u2019s disease. Neural Regen Res. 2022;17:543\u2013549.","journal-title":"Neural Regen Res"},{"issue":"1","key":"e_1_3_4_3_1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s13311-021-01172-w","article-title":"Emotional and neuropsychiatric disorders associated with Alzheimer\u2019s disease","volume":"19","author":"Heilman KM","year":"2022","unstructured":"Heilman KM, Nadeau SE. Emotional and neuropsychiatric disorders associated with Alzheimer\u2019s disease. Neurotherapeutics. 2022;19(1):99\u2013116.","journal-title":"Neurotherapeutics"},{"issue":"4","key":"e_1_3_4_4_1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1021\/ml300058m","article-title":"The \u03b2-amyloid hypothesis in Alzheimer\u2019s disease: seeing is believing","volume":"3","author":"Kung HF.","year":"2012","unstructured":"Kung HF. The \u03b2-amyloid hypothesis in Alzheimer\u2019s disease: seeing is believing. ACS Med Chem Lett. 2012;3(4):265\u2013267.","journal-title":"ACS Med Chem Lett"},{"issue":"1","key":"e_1_3_4_5_1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4161\/cam.3.1.7402","article-title":"Oxidative stress in Alzheimer disease","volume":"3","author":"Gella A","year":"2009","unstructured":"Gella A, Durany N. Oxidative stress in Alzheimer disease. Cell Adh Migr. 2009;3(1):88\u201393.","journal-title":"Cell Adh Migr"},{"issue":"9","key":"e_1_3_4_6_1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders","volume":"8","author":"Ballatore C","year":"2007","unstructured":"Ballatore C, Lee VMY, Trojanowski JQ. Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders. Nat Rev Neurosci. 2007;8(9):663\u2013672.","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"e_1_3_4_7_1","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease","volume":"141","author":"Hampel H","year":"2018","unstructured":"Hampel H, Mesulam M-M, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, Khachaturian AS, Vergallo A, Cavedo E, Snyder PJ, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease. Brain. 2018;141(7):1917\u20131933.","journal-title":"Brain"},{"issue":"2","key":"e_1_3_4_8_1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/jnc.14052","article-title":"Cholinergic modulation of the hippocampal region and memory function","volume":"142","author":"Haam J","year":"2017","unstructured":"Haam J, Yakel JL. Cholinergic modulation of the hippocampal region and memory function. J Neurochem. 2017;142 Suppl 2(Suppl 2):111\u2013121.","journal-title":"J Neurochem"},{"key":"e_1_3_4_9_1","first-page":"1","volume-title":"Behavioral pharmacology of the cholinergic system","author":"Bertrand D","year":"2020","unstructured":"Bertrand D, Wallace TL. A review of the cholinergic system and therapeutic approaches to treat brain disorders. In: Shoaib M, Wallace TL, editors, Behavioral pharmacology of the cholinergic system. Cham: Springer International Publishing; 2020, p. 1\u201328."},{"issue":"17","key":"e_1_3_4_10_1","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/anie.200802808","article-title":"Alzheimer\u2019s disease: from pathology to therapeutic approaches","volume":"48","author":"Jakob-Roetne R","year":"2009","unstructured":"Jakob-Roetne R, Jacobsen H. Alzheimer\u2019s disease: from pathology to therapeutic approaches. Angew Chem Int Ed Engl. 2009;48(17):3030\u20133059.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"3","key":"e_1_3_4_11_1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1570159X11311030006","article-title":"Acetylcholinesterase inhibitors: pharmacology and toxicology","volume":"11","author":"Colovic MB","year":"2013","unstructured":"Colovic MB, Krstic DZ, Lazarevic-Pasti TD, Bondzic AM, Vasic VM. Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol. 2013;11(3):315\u2013335.","journal-title":"Curr Neuropharmacol"},{"issue":"2","key":"e_1_3_4_12_1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00441-006-0239-8","article-title":"Termination and beyond: acetylcholinesterase as a modulator of synaptic transmission","volume":"326","author":"Zimmerman G","year":"2006","unstructured":"Zimmerman G, Soreq H. Termination and beyond: acetylcholinesterase as a modulator of synaptic transmission. Cell Tissue Res. 2006;326(2):655\u2013669.","journal-title":"Cell Tissue Res"},{"issue":"17","key":"e_1_3_4_13_1","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.3390\/ijms22179290","article-title":"Acetylcholinesterase inhibitors in the treatment of neurodegenerative diseases and the role of acetylcholinesterase in their pathogenesis","volume":"22","author":"Walczak-Nowicka \u0141J","year":"2021","unstructured":"Walczak-Nowicka \u0141J, Herbet M. Acetylcholinesterase inhibitors in the treatment of neurodegenerative diseases and the role of acetylcholinesterase in their pathogenesis. Int J Mol Sci. 2021;22(17):9290.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"e_1_3_4_14_1","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/cdd.2015.50","article-title":"The BCL-2 protein family, BH3-mimetics and cancer therapy","volume":"22","author":"Delbridge ARD","year":"2015","unstructured":"Delbridge ARD, Strasser A. The BCL-2 protein family, BH3-mimetics and cancer therapy. Cell Death Differ. 2015;22(7):1071\u20131080.","journal-title":"Cell Death Differ"},{"issue":"1","key":"e_1_3_4_15_1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbrc.2006.01.137","article-title":"Alzheimer\u2019s amyloid \u03b2-peptide (1\u201342) induces cell death in human neuroblastoma via bax\/bcl-2 ratio increase: an intriguing role for methionine 35","volume":"342","author":"Clementi ME","year":"2006","unstructured":"Clementi ME, Pezzotti M, Orsini F, Sampaolese B, Mezzogori D, Grassi C, Giardina B, Misiti F. Alzheimer\u2019s amyloid \u03b2-peptide (1\u201342) induces cell death in human neuroblastoma via bax\/bcl-2 ratio increase: an intriguing role for methionine 35. Biochem Biophys Res Commun. 2006;342(1):206\u2013213.","journal-title":"Biochem Biophys Res Commun"},{"key":"e_1_3_4_16_1","first-page":"105","article-title":"Bace 1","volume":"23","author":"Vassar R.","year":"2004","unstructured":"Vassar R. Bace 1. J Mol Neurosci. 2004;23:105\u2013113.","journal-title":"J Mol Neurosci"},{"issue":"3","key":"e_1_3_4_17_1","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1172\/JCI124853","article-title":"APOE4-mediated amyloid-\u03b2 pathology depends on its neuronal receptor LRP1","volume":"129","author":"Tachibana M","year":"2019","unstructured":"Tachibana M, Holm M-L, Liu C-C, Shinohara M, Aikawa T, Oue H, Yamazaki Y, Martens YA, Murray ME, Sullivan PM, et al. APOE4-mediated amyloid-\u03b2 pathology depends on its neuronal receptor LRP1. J Clin Invest. 2019;129(3):1272\u20131277.","journal-title":"J Clin Invest"},{"issue":"5","key":"e_1_3_4_18_1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/alzrt211","article-title":"The role of APP and BACE1 trafficking in APP processing and amyloid-\u03b2 generation","volume":"5","author":"Zhang X","year":"2013","unstructured":"Zhang X, Song W. The role of APP and BACE1 trafficking in APP processing and amyloid-\u03b2 generation. Alzheimers Res Ther. 2013;5(5):46.","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"e_1_3_4_19_1","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3390\/ph16060848","article-title":"Meloxicam targets COX-2\/NOX1\/NOX4\/Nrf2 axis to ameliorate the depression-like neuropathology induced by chronic restraint stress in rats","volume":"16","author":"Arab HH","year":"2023","unstructured":"Arab HH, Khames A, Mohammad MK, Alsufyani SE, Ashour AM, El-Sheikh AAK, Darwish HW, Gad AM. Meloxicam targets COX-2\/NOX1\/NOX4\/Nrf2 axis to ameliorate the depression-like neuropathology induced by chronic restraint stress in rats. Pharmaceuticals. 2023;16(6):848.","journal-title":"Pharmaceuticals"},{"issue":"2","key":"e_1_3_4_20_1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3390\/ph16020300","article-title":"Targeting the endoplasmic reticulum stress-linked PERK\/GRP78\/CHOP pathway with magnesium sulfate attenuates chronic-restraint-stress-induced depression-like neuropathology in rats","volume":"16","author":"Arab HH","year":"2023","unstructured":"Arab HH, Khames A, Alsufyani SE, El-Sheikh AAK, Gad AM. Targeting the endoplasmic reticulum stress-linked PERK\/GRP78\/CHOP pathway with magnesium sulfate attenuates chronic-restraint-stress-induced depression-like neuropathology in rats. Pharmaceuticals. 2023;16(2):300.","journal-title":"Pharmaceuticals"},{"key":"e_1_3_4_21_1","doi-asserted-by":"crossref","first-page":"135279","DOI":"10.1016\/j.neulet.2020.135279","article-title":"Beta-amyloid activates NLRP3 inflammasome via TLR4 in mouse microglia","volume":"736","author":"Liu Y","year":"2020","unstructured":"Liu Y, Dai Y, Li Q, Chen C, Chen H, Song Y, Hua F, Zhang Z. Beta-amyloid activates NLRP3 inflammasome via TLR4 in mouse microglia. Neurosci Lett. 2020;736:135279.","journal-title":"Neurosci Lett"},{"key":"e_1_3_4_22_1","doi-asserted-by":"crossref","first-page":"114140","DOI":"10.1016\/j.bcp.2020.114140","article-title":"Protective effects of morin against depressive-like behavior prompted by chronic unpredictable mild stress in rats: possible role of inflammasome-related pathways","volume":"180","author":"Hassan M-AM","year":"2020","unstructured":"Hassan M-AM, Gad AM, Menze ET, Badary OA, El-Naga RN. Protective effects of morin against depressive-like behavior prompted by chronic unpredictable mild stress in rats: possible role of inflammasome-related pathways. Biochem Pharmacol. 2020;180:114140.","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"e_1_3_4_23_1","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1007\/s12035-020-01972-9","article-title":"Repurposing of secukinumab as neuroprotective in cuprizone-induced multiple sclerosis experimental model via inhibition of oxidative, inflammatory, and neurodegenerative signaling","volume":"57","author":"Abdel-Maged AE-S","year":"2020","unstructured":"Abdel-Maged AE-S, Gad AM, Rashed LA, Azab SS, Mohamed EA, Awad AS. Repurposing of secukinumab as neuroprotective in cuprizone-induced multiple sclerosis experimental model via inhibition of oxidative, inflammatory, and neurodegenerative signaling. Mol Neurobiol. 2020;57(8):3291\u20133306.","journal-title":"Mol Neurobiol"},{"key":"e_1_3_4_24_1","doi-asserted-by":"crossref","first-page":"o1541","DOI":"10.1107\/S1600536805012808","article-title":"Ethyl 2-amino-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxylate","volume":"61","author":"Nirmala KA","year":"2005","unstructured":"KA, Nirmala Vasu D, Chopra S, Mohan, MR, Prasad. Ethyl 2-amino-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxylate. Acta Crystallographica Section E. 2005;61:o1541\u2013o1543.","journal-title":"Acta Crystallographica Section E"},{"issue":"1","key":"e_1_3_4_25_1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40035-020-00195-1","article-title":"Peripheral clearance of brain-derived A\u03b2 in Alzheimer\u2019s disease: pathophysiology and therapeutic perspectives","volume":"9","author":"Cheng Y","year":"2020","unstructured":"Cheng Y, Tian D-Y, Wang Y-J. Peripheral clearance of brain-derived A\u03b2 in Alzheimer\u2019s disease: pathophysiology and therapeutic perspectives. Transl Neurodegener. 2020;9(1):16.","journal-title":"Transl Neurodegener"},{"issue":"3","key":"e_1_3_4_26_1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s12640-018-9895-1","article-title":"Clearance of amyloid beta and tau in Alzheimer\u2019s disease: from mechanisms to therapy","volume":"34","author":"Xin S-H","year":"2018","unstructured":"Xin S-H, Tan L, Cao X, Yu J-T, Tan L. Clearance of amyloid beta and tau in Alzheimer\u2019s disease: from mechanisms to therapy. Neurotox Res. 2018;34(3):733\u2013748.","journal-title":"Neurotox Res"},{"issue":"1","key":"e_1_3_4_27_1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13041-019-0525-5","article-title":"Restoring Wnt\/\u03b2-catenin signaling is a promising therapeutic strategy for Alzheimer\u2019s disease","volume":"12","author":"Jia L","year":"2019","unstructured":"Jia L, Pi\u00f1a-Crespo J, Li Y. Restoring Wnt\/\u03b2-catenin signaling is a promising therapeutic strategy for Alzheimer\u2019s disease. Mol Brain. 2019;12(1):104.","journal-title":"Mol Brain"},{"issue":"20","key":"e_1_3_4_28_1","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.1523\/JNEUROSCI.0421-09.2009","article-title":"Interruption of \u03b2-catenin signaling reduces neurogenesis in Alzheimer\u2019s disease","volume":"29","author":"He P","year":"2009","unstructured":"He P, Shen Y. Interruption of \u03b2-catenin signaling reduces neurogenesis in Alzheimer\u2019s disease. J Neurosci. 2009;29(20):6545\u20136557.","journal-title":"J Neurosci"},{"issue":"7","key":"e_1_3_4_29_1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1080\/17460441.2020.1746266","article-title":"Targeting the Wnt\/\u03b2-catenin pathway in neurodegenerative diseases: recent approaches and current challenges","volume":"15","author":"Serafino A","year":"2020","unstructured":"Serafino A, Giovannini D, Rossi S, Cozzolino M. Targeting the Wnt\/\u03b2-catenin pathway in neurodegenerative diseases: recent approaches and current challenges. Expert Opin Drug Discov. 2020;15(7):803\u2013822.","journal-title":"Expert Opin Drug Discov"},{"issue":"1","key":"e_1_3_4_30_1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13024-017-0190-z","article-title":"Targeting psychologic stress signaling pathways in Alzheimer\u2019s disease","volume":"12","author":"Futch HS","year":"2017","unstructured":"Futch HS, Croft CL, Truong VQ, Krause EG, Golde TE. Targeting psychologic stress signaling pathways in Alzheimer\u2019s disease. Mol Neurodegeneration. 2017;12(1):49.","journal-title":"Mol Neurodegeneration"},{"issue":"33","key":"e_1_3_4_31_1","doi-asserted-by":"crossref","first-page":"24287","DOI":"10.1039\/D4RA03865G","article-title":"The role of current synthetic and possible plant and marine phytochemical compounds in the treatment of acne","volume":"14","author":"Ramsis T","year":"2024","unstructured":"Ramsis T, Refat HM, Selim M, Elseedy H, Fayed EA. The role of current synthetic and possible plant and marine phytochemical compounds in the treatment of acne. RSC Adv. 2024;14(33):24287\u201324321.","journal-title":"RSC Adv"},{"key":"e_1_3_4_32_1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.conb.2018.06.003","article-title":"Wnt proteins as modulators of synaptic plasticity","volume":"53","author":"McLeod F","year":"2018","unstructured":"McLeod F, Salinas PC. Wnt proteins as modulators of synaptic plasticity. Curr Opin Neurobiol. 2018;53:90\u201395.","journal-title":"Curr Opin Neurobiol"},{"key":"e_1_3_4_33_1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fnsyn.2018.00038","article-title":"Deficient Wnt signaling and synaptic vulnerability in Alzheimer\u2019s disease: emerging roles for the LRP6 receptor","volume":"10","author":"Buechler J","year":"2018","unstructured":"Buechler J, Salinas PC. Deficient Wnt signaling and synaptic vulnerability in Alzheimer\u2019s disease: emerging roles for the LRP6 receptor. Front Synaptic Neurosci. 2018;10:38.","journal-title":"Front Synaptic Neurosci"},{"key":"e_1_3_4_34_1","first-page":"495","article-title":"Synthesis and biological evaluation of new amides pro-drugs containing naproxen moiety as anti-inflammatory and antimicrobial agents","volume":"8","author":"Ammar Y","year":"2016","unstructured":"Ammar Y, Fayed E, Bayoumi A, Saleh M. Synthesis and biological evaluation of new amides pro-drugs containing naproxen moiety as anti-inflammatory and antimicrobial agents. Der Pharma Chemica. 2016;8:495\u2013508.","journal-title":"Der Pharma Chemica"},{"issue":"3","key":"e_1_3_4_35_1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00109-005-0025-1","article-title":"The marijuana component cannabidiol inhibits \u03b2-amyloid-induced tau protein hyperphosphorylation through Wnt\/\u03b2-catenin pathway rescue in PC12 cells","volume":"84","author":"Esposito G","year":"2006","unstructured":"Esposito G, De Filippis D, Carnuccio R, Izzo AA, Iuvone T. The marijuana component cannabidiol inhibits \u03b2-amyloid-induced tau protein hyperphosphorylation through Wnt\/\u03b2-catenin pathway rescue in PC12 cells. J Mol Med (Berl). 2006;84(3):253\u2013258.","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"e_1_3_4_36_1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.yexcr.2004.02.028","article-title":"Wnt-3a overcomes \u03b2-amyloid toxicity in rat hippocampal neurons","volume":"297","author":"Alvarez AR","year":"2004","unstructured":"Alvarez AR, Godoy JA, Mullendorff K, Olivares GH, Bronfman M, Inestrosa NC. Wnt-3a overcomes \u03b2-amyloid toxicity in rat hippocampal neurons. Exp Cell Res. 2004;297(1):186\u2013196.","journal-title":"Exp Cell Res"},{"issue":"2","key":"e_1_3_4_37_1","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.neurobiolaging.2014.09.017","article-title":"Downregulation of canonical Wnt signaling in hippocampus of SAMP8 mice","volume":"36","author":"Bayod S","year":"2015","unstructured":"Bayod S, Felice P, Andr\u00e9s P, Rosa P, Camins A, Pall\u00e0s M, Canudas A-M. Downregulation of canonical Wnt signaling in hippocampus of SAMP8 mice. Neurobiol Aging. 2015;36(2):720\u2013729.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"e_1_3_4_38_1","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1474-9726.2012.00816.x","article-title":"Aging brain microenvironment decreases hippocampal neurogenesis through Wnt-mediated survivin signaling","volume":"11","author":"Miranda CJ","year":"2012","unstructured":"Miranda CJ, Braun L, Jiang Y, Hester ME, Zhang L, Riolo M, Wang H, Rao M, Altura RA, Kaspar BK, et al. Aging brain microenvironment decreases hippocampal neurogenesis through Wnt-mediated survivin signaling. Aging Cell. 2012;11(3):542\u2013552.","journal-title":"Aging Cell"},{"issue":"1","key":"e_1_3_4_39_1","doi-asserted-by":"crossref","first-page":"e23189","DOI":"10.1016\/j.heliyon.2023.e23189","article-title":"Facile synthesis and in vitro anticancer evaluation of a new series of tetrahydroquinoline","volume":"10","author":"Fathy U","year":"2024","unstructured":"Fathy U, Abd El Salam HA, Fayed EA, Elgamal AM, Gouda A. Facile synthesis and in vitro anticancer evaluation of a new series of tetrahydroquinoline. Heliyon. 2024;10(1):e23189.","journal-title":"Heliyon"},{"issue":"2","key":"e_1_3_4_40_1","first-page":"294","article-title":"Synthesis, anxiolytic and tranquilizing activity of some new 1, 4-diazepine derivatives","volume":"7","author":"Mousa BA","unstructured":"Mousa BA, Khalifa MMA, Fayed EA. Synthesis, anxiolytic and tranquilizing activity of some new 1, 4-diazepine derivatives. Am J PharmTech Res. 2017;7(2):294\u2013314.","journal-title":"Am J PharmTech Res"},{"issue":"4","key":"e_1_3_4_41_1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1527-3458.2001.tb00204.x","article-title":"Donepezil for Alzheimer\u2019s disease: pharmacodynamic, pharmacokinetic, and clinical profiles","volume":"7","author":"Shigeta M","year":"2001","unstructured":"Shigeta M, Homma A. Donepezil for Alzheimer\u2019s disease: pharmacodynamic, pharmacokinetic, and clinical profiles. CNS Drug Rev. 2001;7(4):353\u2013368.","journal-title":"CNS Drug Rev"},{"key":"e_1_3_4_42_1","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001191.pub3","article-title":"Rivastigmine for Alzheimer\u2019s disease","volume":"4","author":"Birks JS","year":"2015","unstructured":"Birks JS, Evans JG. Rivastigmine for Alzheimer\u2019s disease. Cochrane Database of Syst Rev. 2015;4:CD001191.","journal-title":"Cochrane Database of Syst Rev"},{"issue":"11","key":"e_1_3_4_43_1","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2165\/00003495-200666110-00015","article-title":"Memantine","volume":"66","author":"Robinson DM","year":"2006","unstructured":"Robinson DM, Keating GM. Memantine. Drugs. 2006;66(11):1515\u20131534.","journal-title":"Drugs"},{"issue":"3","key":"e_1_3_4_44_1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1517\/17425251003592137","article-title":"Galantamine for Alzheimer\u2019s disease","volume":"6","author":"Prvulovic D","year":"2010","unstructured":"Prvulovic D, Hampel H, Pantel J. Galantamine for Alzheimer\u2019s disease. Expert Opin Drug Metab Toxicol. 2010;6(3):345\u2013354.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"2","key":"e_1_3_4_45_1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-132690","article-title":"Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"41","author":"Tan C-C","year":"2014","unstructured":"Tan C-C, Yu J-T, Wang H-F, Tan M-S, Meng X-F, Wang C, Jiang T, Zhu X-C, Tan L. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer\u2019s disease: a systematic review and meta-analysis. J Alzheimers Dis. 2014;41(2):615\u2013631.","journal-title":"J Alzheimers Dis"},{"key":"e_1_3_4_46_1","doi-asserted-by":"crossref","first-page":"117201","DOI":"10.1016\/j.ejmech.2024.117201","article-title":"Discovery of novel bicyclic and tricyclic cyclohepta[b]thiophene derivatives as multipotent AChE and BChE inhibitors, in-Vivo and in-Vitro assays, ADMET and molecular docking simulation","volume":"284","author":"Fayed EA","year":"2025","unstructured":"Fayed EA, El-Sebaey SA, Ebrahim MA, Abu-Elfotuh K, El-Sayed Mansour R, Mohamed EK, Hamdan AME, Al-Subaie FT, Albalawi GS, Albalawi TM, et al. Discovery of novel bicyclic and tricyclic cyclohepta[b]thiophene derivatives as multipotent AChE and BChE inhibitors, in-Vivo and in-Vitro assays, ADMET and molecular docking simulation. Eur J Med Chem. 2025;284:117201.","journal-title":"Eur J Med Chem"},{"issue":"2","key":"e_1_3_4_47_1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.mehy.2004.02.031","article-title":"Brain cholinesterases: II. The molecular and cellular basis of Alzheimer\u2019s disease","volume":"63","author":"Shen ZX.","year":"2004","unstructured":"Shen ZX. Brain cholinesterases: II. The molecular and cellular basis of Alzheimer\u2019s disease. Med Hypotheses. 2004;63(2):308\u2013321.","journal-title":"Med Hypotheses"},{"issue":"3","key":"e_1_3_4_48_1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1023\/A:1022869222652","article-title":"Cholinesterases: new roles in brain function and in Alzheimer\u2019s disease","volume":"28","author":"Giacobini E.","year":"2003","unstructured":"Giacobini E. Cholinesterases: new roles in brain function and in Alzheimer\u2019s disease. Neurochem Res. 2003;28(3-4):515\u2013522.","journal-title":"Neurochem Res"},{"issue":"4","key":"e_1_3_4_49_1","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.3390\/ijms22042033","article-title":"The role of butyrylcholinesterase and iron in the regulation of cholinergic network and cognitive dysfunction in Alzheimer\u2019s disease pathogenesis","volume":"22","author":"Jasiecki J","year":"2021","unstructured":"Jasiecki J, Targo\u0144ska M, Was\u0105g B. The role of butyrylcholinesterase and iron in the regulation of cholinergic network and cognitive dysfunction in Alzheimer\u2019s disease pathogenesis. int J Mol Sci. 2021;22(4):2033.","journal-title":"int J Mol Sci"},{"key":"e_1_3_4_50_1","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejmech.2017.03.062","article-title":"Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer\u2019s disease","volume":"132","author":"Li Q","year":"2017","unstructured":"Li Q, Yang H, Chen Y, Sun H. Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer\u2019s disease. Eur J Med Chem. 2017;132:294\u2013309.","journal-title":"Eur J Med Chem"},{"issue":"23","key":"e_1_3_4_51_1","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.3390\/molecules24234217","article-title":"Discovery of selective butyrylcholinesterase (BChE) inhibitors through a combination of computational studies and biological evaluations","volume":"24","author":"Zhou Y","year":"2019","unstructured":"Zhou Y, Lu X, Yang H, Chen Y, Wang F, Li J, Tang Z, Cheng X, Yang Y, Xu L, et al. Discovery of selective butyrylcholinesterase (BChE) inhibitors through a combination of computational studies and biological evaluations. Molecules. 2019;24(23):4217.","journal-title":"Molecules"},{"issue":"7","key":"e_1_3_4_52_1","doi-asserted-by":"crossref","first-page":"110451","DOI":"10.1016\/j.cclet.2024.110451","article-title":"Advances in design strategies and imaging applications of specific butyrylcholinesterase probes","volume":"36","author":"Sun T","year":"2025","unstructured":"Sun T, Dong Z, Malugulu PM, Zhen T, Wang L, Chen Y, Sun H. Advances in design strategies and imaging applications of specific butyrylcholinesterase probes. Chin Chem Lett. 2025;36(7):110451.","journal-title":"Chin Chem Lett"},{"issue":"1","key":"e_1_3_4_53_1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/biom10010040","article-title":"Alzheimer\u2019s disease pharmacotherapy in relation to cholinergic system involvement","volume":"10","author":"Stanciu GD","year":"2019","unstructured":"Stanciu GD, Luca A, Rusu RN, Bild V, Beschea Chiriac SI, Solcan C, Bild W, Ababei DC. Alzheimer\u2019s disease pharmacotherapy in relation to cholinergic system involvement. Biomolecules. 2019;10(1):40.","journal-title":"Biomolecules"},{"issue":"132","key":"e_1_3_4_54_1","first-page":"1241","article-title":"Design, synthesis, and biological evaluation of a novel series of thiazole derivatives based on pyrazoline as anticancer agents","volume":"65","author":"Fathy U","year":"2022","unstructured":"Fathy U, Yousif MNM, Mohi El-Deen EM, Fayed EA. Design, synthesis, and biological evaluation of a novel series of thiazole derivatives based on pyrazoline as anticancer agents. Egypt J Chem. 2022;65(132):1241\u20131252.","journal-title":"Egypt J Chem"},{"issue":"2","key":"e_1_3_4_55_1","doi-asserted-by":"crossref","first-page":"131018","DOI":"10.1016\/j.ijbiomac.2024.131018","article-title":"Fused thiophene as a privileged scaffold: a review on anti-Alzheimer\u2019s disease potentials via targeting cholinesterases, monoamine oxidases, glycogen synthase kinase-3, and A\u03b2 aggregation","volume":"265","author":"Kassab AE","year":"2024","unstructured":"Kassab AE, Gedawy EM, Sayed AS. Fused thiophene as a privileged scaffold: a review on anti-Alzheimer\u2019s disease potentials via targeting cholinesterases, monoamine oxidases, glycogen synthase kinase-3, and A\u03b2 aggregation. Int J Biol Macromol. 2024;265(Pt 2):131018.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"e_1_3_4_56_1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13065-017-0294-0","article-title":"Erratum: one pot synthesis, antimicrobial and antioxidant activities of fused uracils: pyrimidodiazepines, lumazines, triazolouracil and xanthines. [Chem Cent J 11, (2017) (66)]","volume":"11","author":"El-Kalyoubi SA","year":"2017","unstructured":"El-Kalyoubi SA, Fayed EA, Abdel-Razek AS. Erratum: one pot synthesis, antimicrobial and antioxidant activities of fused uracils: pyrimidodiazepines, lumazines, triazolouracil and xanthines. [Chem Cent J 11, (2017) (66)]. Chem Cent J. 2017;11(1):66.,","journal-title":"Chem Cent J"},{"issue":"1","key":"e_1_3_4_57_1","doi-asserted-by":"crossref","first-page":"e23189","DOI":"10.1016\/j.heliyon.2023.e23189","article-title":"Erratum to \u201cfacile synthesis and in vitro anticancer evaluation of a new series of tetrahydroquinoline\u201d [Heliyon 7(10) (October 2021) e08117] (Heliyon (2021) 7(10), (S2405844021022209)","volume":"10","author":"Fathy U","year":"2024","unstructured":"Fathy U, Abd El Salam HA, Fayed EA, Elgamal AM, Gouda A. Erratum to \u201cfacile synthesis and in vitro anticancer evaluation of a new series of tetrahydroquinoline\u201d [Heliyon 7(10) (October 2021) e08117] (Heliyon (2021) 7(10), (S2405844021022209). Heliyon. 2024;10(1):e23189.","journal-title":"Heliyon"},{"issue":"7","key":"e_1_3_4_58_1","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3390\/ph14070692","article-title":"Thiophene-based compounds with potential anti-inflammatory activity","volume":"14","author":"da Cruz RMD","year":"2021","unstructured":"da Cruz RMD, Mendon\u00e7a-Junior FJB, de M\u00e9lo NB, Scotti L, de Ara\u00fajo RSA, de Almeida RN, de Moura RO. Thiophene-based compounds with potential anti-inflammatory activity. Pharmaceuticals. 2021;14(7):692.","journal-title":"Pharmaceuticals"},{"issue":"8","key":"e_1_3_4_59_1","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3390\/ph18081214","article-title":"Unlocking therapeutic potential of novel thieno-oxazepine hybrids as multi-target inhibitors of AChE\/BChE and evaluation against Alzheimer\u2019s disease: in vivo, in vitro, histopathological, and docking studies","volume":"18","author":"Oudah KH","year":"2025","unstructured":"Oudah KH, Najm MAA, Ramsis TM, Ebrahim MA, Gohar NA, Abu-Elfotuh K, Mohamed EK, Hamdan AME, Hamdan AM, Almotairi R, et al. Unlocking therapeutic potential of novel thieno-oxazepine hybrids as multi-target inhibitors of AChE\/BChE and evaluation against Alzheimer\u2019s disease: in vivo, in vitro, histopathological, and docking studies. Pharmaceuticals. 2025;18(8):1214.","journal-title":"Pharmaceuticals"},{"key":"e_1_3_4_60_1","first-page":"77","article-title":"Synthesis, characterization and pharmacological evaluation of some new 1,4-diazepine derivatives as anticancer agents","volume":"8","author":"Fayed E","year":"2016","unstructured":"Fayed E, Youssef H. Synthesis, characterization and pharmacological evaluation of some new 1,4-diazepine derivatives as anticancer agents. Der Pharma Chemica. 2016;8:77\u201390.","journal-title":"Der Pharma Chemica"},{"issue":"8","key":"e_1_3_4_61_1","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3390\/ph15081008","article-title":"Neuroprotective effects of phytochemicals against aluminum chloride-induced Alzheimer\u2019s disease through ApoE4\/LRP1, Wnt3\/\u03b2-Catenin\/GSK3\u03b2, and TLR4\/NLRP3 pathways with physical and mental activities in a rat model","volume":"15","author":"Hamdan AME","year":"2022","unstructured":"Hamdan AME, Alharthi FHJ, Alanazi AH, El-Emam SZ, Zaghlool SS, Metwally K, Albalawi SA, Abdu YS, Mansour RE-S, Salem HA, et al. Neuroprotective effects of phytochemicals against aluminum chloride-induced Alzheimer\u2019s disease through ApoE4\/LRP1, Wnt3\/\u03b2-Catenin\/GSK3\u03b2, and TLR4\/NLRP3 pathways with physical and mental activities in a rat model. Pharmaceuticals. 2022;15(8):1008.","journal-title":"Pharmaceuticals"},{"key":"e_1_3_4_62_1","first-page":"269","article-title":"Synthesis, anxiolytic and antimicrobial activity of some novel 5-oxo-1, 4-oxazepine derivatives","volume":"33","author":"Abdel Fattah B","year":"2010","unstructured":"Abdel Fattah B, Khalifa M, El-Sehraswi H, Fayed E, Bayoumi A, Said M. Synthesis, anxiolytic and antimicrobial activity of some novel 5-oxo-1, 4-oxazepine derivatives. J Egypt Biomed Sci. 2010;33:269.","journal-title":"J Egypt Biomed Sci"},{"key":"e_1_3_4_63_1","first-page":"2017","article-title":"Synthesis, anxiolytic and tranquilizing activity of some new 1, 4-diazepine derivatives","volume":"7","author":"Mousa B","year":"2017","unstructured":"Mousa B, Khalifa M, Fayed E, Said M, Ahmed H. Synthesis, anxiolytic and tranquilizing activity of some new 1, 4-diazepine derivatives. Am J PharmTech Res. 2017;7:2017.","journal-title":"Am J PharmTech Res"},{"issue":"4","key":"e_1_3_4_64_1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2174\/157018011794839448","article-title":"Synthesis and anxiolytic activity of some novel 5-oxo-1, 4-oxazepine derivatives","volume":"8","author":"A. AbdelFattah B","year":"2011","unstructured":"A. AbdelFattah B, M.a. Khalifa M, El-Sehrawi H, Fayed E, Bayoumi A, Said M. Synthesis and anxiolytic activity of some novel 5-oxo-1, 4-oxazepine derivatives. Lett Drug Des Discovery. 2011;8(4):330\u2013338.","journal-title":"Lett Drug Des Discovery"},{"issue":"1","key":"e_1_3_4_65_1","doi-asserted-by":"crossref","first-page":"100146","DOI":"10.1016\/j.phyplu.2021.100146","article-title":"Comparative study on the effect of EGCG and wheat grass together with mental and physical activities against induction of Alzheimer\u2019s disease in both isolated and socialized rats","volume":"2","author":"Khalil MG","year":"2022","unstructured":"Khalil MG, Ali AA, Hassanin SO, Al-Najjar AH, Ghosh S, Mahmoud MO. Comparative study on the effect of EGCG and wheat grass together with mental and physical activities against induction of Alzheimer\u2019s disease in both isolated and socialized rats. Phytomed Plus. 2022;2(1):100146.","journal-title":"Phytomed Plus"},{"issue":"1","key":"e_1_3_4_66_1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","article-title":"Developments of a water-maze procedure for studying spatial learning in the rat","volume":"11","author":"Morris R.","year":"1984","unstructured":"Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods. 1984;11(1):47\u201360.","journal-title":"J Neurosci Methods"},{"issue":"164","key":"e_1_3_4_67_1","first-page":"e61806","article-title":"Behavioral assessment of visual function via optomotor response and cognitive function via Y-Maze in diabetic rats","author":"Gudapati K","year":"2020","unstructured":"Gudapati K, Singh A, Clarkson-Townsend D, Phillips SQ, Douglass A, Feola AJ, Allen RS. Behavioral assessment of visual function via optomotor response and cognitive function via Y-Maze in diabetic rats. J Vis Exp. 2020;(164):e61806; Erratum in: J Vis Exp. 2022;(179):e6487.","journal-title":"J Vis Exp"},{"issue":"3","key":"e_1_3_4_68_1","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s10103-021-03410-1","article-title":"Antidepressant and antioxidant effects of transcranial irradiation with 830-nm low-power laser in an animal model of depression","volume":"37","author":"Mohammed HS","year":"2022","unstructured":"Mohammed HS, Khadrawy YA. Antidepressant and antioxidant effects of transcranial irradiation with 830-nm low-power laser in an animal model of depression. Lasers Med Sci. 2022;37(3):1615\u20131623.","journal-title":"Lasers Med Sci"},{"issue":"3","key":"e_1_3_4_69_1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","article-title":"Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase","volume":"47","author":"Marklund S","year":"1974","unstructured":"Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974;47(3):469\u2013474.","journal-title":"Eur J Biochem"},{"issue":"5","key":"e_1_3_4_70_1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/jcp.54.5.356","article-title":"Method for the measurement of antioxidant activity in human fluids","volume":"54","author":"Koracevic D","year":"2001","unstructured":"Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol. 2001;54(5):356\u2013361.","journal-title":"J Clin Pathol"},{"issue":"9","key":"e_1_3_4_71_1","first-page":"e14462","article-title":"Changes of serum IL-10, IL-1\u03b2, IL-6, MCP-1, TNF-\u03b1, IP-10 and IL-4 in COVID-19 patients","volume":"75","author":"Lu Q","year":"2021","unstructured":"Lu Q, Zhu Z, Tan C, Zhou H, Hu Y, Shen G, Zhu P, Yang G, Xie X. Changes of serum IL-10, IL-1\u03b2, IL-6, MCP-1, TNF-\u03b1, IP-10 and IL-4 in COVID-19 patients. Int J Clin Pract. 2021;75(9):e14462.","journal-title":"Int J Clin Pract"},{"issue":"3","key":"e_1_3_4_72_1","first-page":"1032","article-title":"Wnt2 promotes non-small cell lung cancer progression by activating WNT\/\u03b2-catenin pathway","volume":"5","author":"Huang C","year":"2015","unstructured":"Huang C, Ma R, Xu Y, Li N, Li Z, Yue J, Li H, Guo Y, Qi D. Wnt2 promotes non-small cell lung cancer progression by activating WNT\/\u03b2-catenin pathway. Am J Cancer Res. 2015;5(3):1032\u20131046.","journal-title":"Am J Cancer Res"},{"issue":"2","key":"e_1_3_4_73_1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman GL","year":"1961","unstructured":"Ellman GL, Courtney KD, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7(2):88\u201395.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"e_1_3_4_74_1","doi-asserted-by":"crossref","first-page":"11446","DOI":"10.1038\/s41598-023-38143-4","article-title":"Araucaria heterophylla oleogum resin essential oil is a novel aldose reductase and butyryl choline esterase enzymes inhibitor: in vitro and in silico evidence","volume":"13","author":"Soliman AF","year":"2023","unstructured":"Soliman AF, Sabry MA, Abdelwahab G. Araucaria heterophylla oleogum resin essential oil is a novel aldose reductase and butyryl choline esterase enzymes inhibitor: in vitro and in silico evidence. Sci Rep. 2023;13(1):11446.","journal-title":"Sci Rep"},{"issue":"17","key":"e_1_3_4_75_1","doi-asserted-by":"crossref","first-page":"9695","DOI":"10.1021\/acs.jmedchem.0c00756","article-title":"MicroRNA-based multitarget approach for Alzheimer\u2019s disease: discovery of the first-in-class dual inhibitor of acetylcholinesterase and MicroRNA-15b biogenesis","volume":"63","author":"Gabr MT","year":"2020","unstructured":"Gabr MT, Brogi S. MicroRNA-based multitarget approach for Alzheimer\u2019s disease: discovery of the first-in-class dual inhibitor of acetylcholinesterase and MicroRNA-15b biogenesis. J Med Chem. 2020;63(17):9695\u20139704.","journal-title":"J Med Chem"},{"key":"e_1_3_4_76_1","doi-asserted-by":"crossref","first-page":"136663","DOI":"10.1016\/j.molstruc.2023.136663","article-title":"Pyrano-coumarin hybrids as potential antimicrobial agents against MRSA strains: design, synthesis, ADMET, molecular docking studies, as DNA gyrase inhibitors","volume":"1295","author":"Fayed EA","year":"2024","unstructured":"Fayed EA, Ebrahim MA, Fathy U, Elawady AM, Khalaf WS, Ramsis TM. Pyrano-coumarin hybrids as potential antimicrobial agents against MRSA strains: design, synthesis, ADMET, molecular docking studies, as DNA gyrase inhibitors. J Mol Struct. 2024;1295:136663.","journal-title":"J Mol Struct"},{"key":"e_1_3_4_77_1","doi-asserted-by":"crossref","first-page":"137374","DOI":"10.1016\/j.molstruc.2023.137374","article-title":"Fluorinated thiazole\u2013thiosemicarbazones hybrids as potential PPAR-\u03b3 agonist and \u03b1-amylase, \u03b1-glucosidase antagonists: design, synthesis, in silico ADMET and docking studies and hypoglycemic evaluation","volume":"1301","author":"Fayed EA","year":"2024","unstructured":"Fayed EA, Thabet A, El-Gilil SMA, Elsanhory HMA, Ammar YA. Fluorinated thiazole\u2013thiosemicarbazones hybrids as potential PPAR-\u03b3 agonist and \u03b1-amylase, \u03b1-glucosidase antagonists: design, synthesis, in silico ADMET and docking studies and hypoglycemic evaluation. J Mol Struct. 2024;1301:137374.","journal-title":"J Mol Struct"},{"issue":"1","key":"e_1_3_4_78_1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s13065-025-01566-3","article-title":"Flufenamic acid-based sulfonohydrazide and acetamide derivatives NSAI as inhibitors of multi-targets COX-1\/COX-2\/5-LOX: design, synthesis, in silico ADMET and binding mode studies","volume":"19","author":"Hussein S","year":"2025","unstructured":"Hussein S, Fayed EA, Ragab A, Abusaif MS, Ammar YA, El-Sayed Mansou R, Musa A, Ramsis TM. Flufenamic acid-based sulfonohydrazide and acetamide derivatives NSAI as inhibitors of multi-targets COX-1\/COX-2\/5-LOX: design, synthesis, in silico ADMET and binding mode studies. BMC Chem. 2025;19(1):271.","journal-title":"BMC Chem"},{"issue":"1","key":"e_1_3_4_79_1","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong G","year":"2021","unstructured":"Xiong G, Wu Z, Yi J, Fu L, Yang Z, Hsieh C, Yin M, Zeng X, Wu C, Lu A, et al. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res. 2021;49(W1):W5\u2013W14.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"e_1_3_4_80_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13321-018-0283-x","article-title":"ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database","volume":"10","author":"Dong J","year":"2018","unstructured":"Dong J, Wang N-N, Yao Z-J, Zhang L, Cheng Y, Ouyang D, Lu A-P, Cao D-S. ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database. J Cheminform. 2018;10(1):29.","journal-title":"J Cheminform"},{"issue":"9","key":"e_1_3_4_81_1","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires DEV","year":"2015","unstructured":"Pires DEV, Blundell TL, Ascher DB. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015;58(9):4066\u20134072.","journal-title":"J Med Chem"},{"issue":"1","key":"e_1_3_4_82_1","doi-asserted-by":"crossref","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee P","year":"2018","unstructured":"Banerjee P, Eckert AO, Schrey AK, Preissner R. ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 2018;46(W1):W257\u2013W263.","journal-title":"Nucleic Acids Res"},{"issue":"22","key":"e_1_3_4_83_1","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung J","year":"2012","unstructured":"Cheung J, Rudolph MJ, Burshteyn F, Cassidy MS, Gary EN, Love J, Franklin MC, Height JJ. Structures of human acetylcholinesterase in complex with pharmacologically important ligands. J Med Chem. 2012;55(22):10282\u201310286.","journal-title":"J Med Chem"},{"issue":"3","key":"e_1_3_4_84_1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/BJ20130013","article-title":"Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer\u2019s drugs targeting acetyl- and butyryl-cholinesterase","volume":"453","author":"Nachon F","year":"2013","unstructured":"Nachon F, Carletti E, Ronco C, Trovaslet M, Nicolet Y, Jean L, Renard P-Y. Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer\u2019s drugs targeting acetyl- and butyryl-cholinesterase. Biochem J. 2013;453(3):393\u2013399.","journal-title":"Biochem J"},{"key":"e_1_3_4_85_1","article-title":"Unveiling of the novel benzothiazole derived thiazolidinone derivatives: in vitro and in silico insights to design a promising agent for anti-Alzheimer\u2019s disease","author":"Khan Y","year":"2025","unstructured":"Khan Y, Mukhtiar A, Sarfraz H, Khan S, Hussain R, Naeem MU, Sattar A, Aziz T, Panezai ZUR, Albekairi TH, et al. Unveiling of the novel benzothiazole derived thiazolidinone derivatives: in vitro and in silico insights to design a promising agent for anti-Alzheimer\u2019s disease. Zeitschrift F\u00fcr Naturforschung C. 2025;6.","journal-title":"Zeitschrift F\u00fcr Naturforschung C"},{"issue":"1","key":"e_1_3_4_86_1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13065-024-01340-x","article-title":"Novel pyrrole based triazole moiety as therapeutic hybrid: synthesis, characterization and anti-Alzheimer potential with molecular mechanism of protein ligand profile","volume":"18","author":"Khan S","year":"2024","unstructured":"Khan S, Iqbal T, Khan MB, Hussain R, Khan Y, Darwish HW. Novel pyrrole based triazole moiety as therapeutic hybrid: synthesis, characterization and anti-Alzheimer potential with molecular mechanism of protein ligand profile. BMC Chem. 2024;18(1):223\u2013211.","journal-title":"BMC Chem"},{"key":"e_1_3_4_87_1","unstructured":"Molecular operating environment (MOE) 2014.09 chemical computing group ULC 1010 Sherbooke St. West Suite #910 Montreal QC Canada H3A 2R7 2014. https:\/\/www.chemcomp.com\/"},{"issue":"12","key":"e_1_3_4_88_1","first-page":"171","article-title":"Synthesis, docking and anticancer activity of some new thienopyrimidine and thienooxazine derivatives","volume":"12","author":"Shawer TZ","unstructured":"Shawer TZ, Fayed EA. Synthesis, docking and anticancer activity of some new thienopyrimidine and thienooxazine derivatives. Nat Sci. 2014;12(12):171\u2013181.","journal-title":"Nat Sci"},{"issue":"1","key":"e_1_3_4_89_1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13568-023-01633-9","article-title":"Interception of epoxide ring to quorum sensing system in Enterococcus faecalis and Staphylococcus aureus","volume":"13","author":"Refai MY","year":"2023","unstructured":"Refai MY, Elazzazy AM, Desouky SE, Abu-Elghait M, Fayed EA, Alajel SM, Alajlan AA, Albureikan MO, Nakayama J. Interception of epoxide ring to quorum sensing system in Enterococcus faecalis and Staphylococcus aureus. AMB Express. 2023;13(1):126.","journal-title":"AMB Express"},{"key":"e_1_3_4_90_1","doi-asserted-by":"crossref","first-page":"140325","DOI":"10.1016\/j.molstruc.2024.140325","article-title":"A versatile inhibitory approach and molecular mechanism on cancer cells and cholinesterase enzymes: synthesis, DFT, ADMET and molecular docking of thiadiazole and oxadiazole derivatives","volume":"1322","author":"Iqbal T","year":"2025","unstructured":"Iqbal T, Khan S, Hussain R, Khan Y, Rahim F, Hayat A, Awwad NS, Alkhathami AG. A versatile inhibitory approach and molecular mechanism on cancer cells and cholinesterase enzymes: synthesis, DFT, ADMET and molecular docking of thiadiazole and oxadiazole derivatives. J Mol Struct. 2025;1322:140325. \/02\/15\/2025.","journal-title":"J Mol Struct"},{"key":"e_1_3_4_91_1","doi-asserted-by":"crossref","first-page":"136439","DOI":"10.1016\/j.molstruc.2023.136439","article-title":"Hybrid molecules of thiadiazole-based benzothioate and benzenesulfonothioate: synthesis, structural analysis, and evaluation as potential inhibitors of thymidine phosphorylase and \u03b2-glucuronidase through in vitro and in silico approaches","volume":"1294","author":"Khan Y","year":"2023","unstructured":"Khan Y, Khan S, Rehman W, Hussain R, Maalik A, Ali F, Khan MU, Sattar A, Assiri MA. Hybrid molecules of thiadiazole-based benzothioate and benzenesulfonothioate: synthesis, structural analysis, and evaluation as potential inhibitors of thymidine phosphorylase and \u03b2-glucuronidase through in vitro and in silico approaches. J Mol Struct. 2023;1294:136439.","journal-title":"J Mol Struct"},{"key":"e_1_3_4_92_1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/9781119896869.ch5","volume-title":"Applied biotechnology and bioinformatics: agriculture, pharmaceutical research and environment","author":"Elseedy HA","year":"2024","unstructured":"Elseedy HA, Kiriacos C, Ramsis TM. Molecular modeling and drug development. In: Applied biotechnology and bioinformatics: agriculture, pharmaceutical research and environment. 2024, p. 109\u2013137. Wiley-Scrivener."},{"issue":"2","key":"e_1_3_4_93_1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.21608\/aijpms.2025.297590.1277","article-title":"Bis-thiazole hybrids as promising candidates in controlling diabetes mellitus in vivo, in vitro evaluation, in silico ADMET, and docking studies","volume":"5","author":"Thabet A","year":"2025","unstructured":"Thabet A, Samir Abusaif M, Ammar YA, Abd-Elgilil SM, Elsanhory H, Fayed EA. Bis-thiazole hybrids as promising candidates in controlling diabetes mellitus in vivo, in vitro evaluation, in silico ADMET, and docking studies. Azhar Int J Pharm Med Sci. 2025;5(2):87\u2013105.","journal-title":"Azhar Int J Pharm Med Sci"},{"key":"e_1_3_4_94_1","doi-asserted-by":"crossref","first-page":"140082","DOI":"10.1016\/j.molstruc.2024.140082","article-title":"Discovery of thiourea based acetylcholinesterase inhibitors and antibacterial agents: synthesis, in vitro, structure-activity relationship and in silico study","volume":"1321","author":"Maalik A","year":"2025","unstructured":"Maalik A, Khan I, Rehman W, Faiz S, Alanazi AS, Hefnawy M, Rasheed L, Hassan SI, Hussain R, Abdellattif MH, et al. Discovery of thiourea based acetylcholinesterase inhibitors and antibacterial agents: synthesis, in vitro, structure-activity relationship and in silico study. J Mol Struct. 2025;1321:140082. \/02\/05\/2025.","journal-title":"J Mol Struct"},{"issue":"10","key":"e_1_3_4_95_1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2174\/0113895575320413250126041041","article-title":"Innovative horizons in drug design: exploring the synthesis and medicinal properties of heterocyclic schiff bases. A review","volume":"25","author":"Khan Y","year":"2025","unstructured":"Khan Y, Sarfraz H, Rehman W, Khan M, Rasheed L, Rahman KU. Innovative horizons in drug design: exploring the synthesis and medicinal properties of heterocyclic schiff bases. A review. Mini Rev Med Chem. 2025;25(10):727\u2013744.","journal-title":"Mini Rev Med Chem"},{"issue":"3","key":"e_1_3_4_96_1","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3390\/metabo12030246","article-title":"Secondary metabolites of actinomycetales as potent quorum sensing inhibitors targeting gram-positive pathogens: in vitro and in silico study","volume":"12","author":"Desouky SE","year":"2022","unstructured":"Desouky SE, Abu-Elghait M, Fayed EA, Selim S, Yousuf B, Igarashi Y, Abdel-Wahab BA, Mohammed Alsuhaibani A, Sonomoto K, Nakayama J, et al. Secondary metabolites of actinomycetales as potent quorum sensing inhibitors targeting gram-positive pathogens: in vitro and in silico study. Metabolites. 2022;12(3):246.","journal-title":"Metabolites"},{"issue":"7","key":"e_1_3_4_97_1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1515\/znc-2024-0175","article-title":"Synthesis, in vitro anti-urease, in-silico molecular docking study and ADMET predictions of piperidine and piperazine Morita-Baylis-Hillman Adducts (MBHAs)","volume":"80","author":"Aslam S","year":"2025","unstructured":"Aslam S, Ullah S, Ullah H, Rehman AU, Khan N, Baqi A, Khan Y. Synthesis, in vitro anti-urease, in-silico molecular docking study and ADMET predictions of piperidine and piperazine Morita-Baylis-Hillman Adducts (MBHAs). Z Naturforsch C J Biosci. 2025;80(7-8):361\u2013373.","journal-title":"Z Naturforsch C J Biosci"},{"issue":"6","key":"e_1_3_4_98_1","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s13738-025-03216-w","article-title":"Medicinal approaches toward diabetes mellitus based on chloro-1H-indazole-derived triazolo-thiadiazole hybrid derivatives: design, synthesis, characterization, in vitro and in silico insights","volume":"22","author":"Khan Y","year":"2025","unstructured":"Khan Y, Khan S, Hussain R, Mukhtar A, Sarfraz H, Aminullah S. Medicinal approaches toward diabetes mellitus based on chloro-1H-indazole-derived triazolo-thiadiazole hybrid derivatives: design, synthesis, characterization, in vitro and in silico insights. J Iran Chem Soc. 2025\/06\/01 2025;22(6):1209\u20131227.","journal-title":"J Iran Chem Soc"},{"issue":"21","key":"e_1_3_4_99_1","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1002\/ejoc.201600496","article-title":"Efficient O-acylation of alcohols and phenol using Cp2TiCl as a reaction promoter","volume":"2016","author":"Dur\u00e1n-Pe\u00f1a MJ","year":"2016","unstructured":"Dur\u00e1n-Pe\u00f1a MJ, Botubol-Ares JM, Hanson JR, Hern\u00e1ndez-Gal\u00e1n R, Collado IG. Efficient O-acylation of alcohols and phenol using Cp2TiCl as a reaction promoter. Eur J Org Chem. 2016;2016(21):3584\u20133591.","journal-title":"Eur J Org Chem"},{"issue":"1","key":"e_1_3_4_100_1","first-page":"69","article-title":"Acetylation of alcohols, amines, phenols, thiols under catalyst and solvent-free conditions","volume":"1","author":"Anbu N","year":"2019","unstructured":"Anbu N, Nagarjun N, Jacob M, Kalaiarasi JMVK, Dhakshinamoorthy A. Acetylation of alcohols, amines, phenols, thiols under catalyst and solvent-free conditions. Chemistry (Easton). 2019;1(1):69\u201379.","journal-title":"Chemistry (Easton)"},{"issue":"11","key":"e_1_3_4_101_1","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.3390\/molecules23112925","article-title":"Quinazolin-4(3H)-ones and 5,6-dihydropyrimidin-4(3H)-ones from \u03b2-aminoamides and orthoesters","volume":"23","author":"Gavin JT","year":"2018","unstructured":"Gavin JT, Annor-Gyamfi JK, Bunce RA. Quinazolin-4(3H)-ones and 5,6-dihydropyrimidin-4(3H)-ones from \u03b2-aminoamides and orthoesters. Molecules. 2018;23(11):2925.","journal-title":"Molecules"},{"issue":"19","key":"e_1_3_4_102_1","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.3390\/molecules24193555","article-title":"4H-benzo[d][1,3]oxazin-4-ones and dihydro Analogs from substituted anthranilic acids and orthoesters","volume":"24","author":"Annor-Gyamfi JK","year":"2019","unstructured":"Annor-Gyamfi JK, Bunce RA. 4H-benzo[d][1,3]oxazin-4-ones and dihydro Analogs from substituted anthranilic acids and orthoesters. Molecules. 2019;24(19):3555.","journal-title":"Molecules"},{"issue":"26","key":"e_1_3_4_103_1","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1021\/jm060642i","article-title":"Structure\u2009\u2212\u2009brain exposure relationships","volume":"49","author":"Hitchcock SA","year":"2006","unstructured":"Hitchcock SA, Pennington LD. Structure\u2009\u2212\u2009brain exposure relationships. J Med Chem. 2006;49(26):7559\u20137583.","journal-title":"J Med Chem"},{"issue":"4","key":"e_1_3_4_104_1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ejps.2013.04.024","article-title":"1,4-Substituted 4-(1H)-pyridylene-hydrazone-type inhibitors of AChE, BuChE, and amyloid-\u03b2 aggregation crossing the blood\u2013brain barrier","volume":"49","author":"Prinz M","year":"2013","unstructured":"Prinz M, Parlar S, Bayraktar G, Alpt\u00fcz\u00fcn V, Erciyas E, Fallarero A, Karlsson D, Vuorela P, Burek M, F\u00f6rster C, et al. 1,4-Substituted 4-(1H)-pyridylene-hydrazone-type inhibitors of AChE, BuChE, and amyloid-\u03b2 aggregation crossing the blood\u2013brain barrier. Eur J Pharm Sci. 2013;49(4):603\u2013613.","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"e_1_3_4_105_1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1021\/acs.jcim.6b00465","article-title":"Phantom PAINS: problems with the utility of alerts for Pan-Assay INterference CompoundS","volume":"57","author":"Capuzzi SJ","year":"2017","unstructured":"Capuzzi SJ, Muratov EN, Tropsha A. Phantom PAINS: problems with the utility of alerts for Pan-Assay INterference CompoundS. J Chem Inf Model. 2017;57(3):417\u2013427.","journal-title":"J Chem Inf Model"},{"issue":"5","key":"e_1_3_4_106_1","doi-asserted-by":"crossref","first-page":"2100454","DOI":"10.1002\/ardp.202100454","article-title":"Upregulation of BAX and caspase\u20103, as well as downregulation of Bcl\u20102 during treatment with indeno[1,2\u2010b]quinoxalin derivatives, mediated apoptosis in human \u2026","volume":"355","author":"Fayed EA","year":"2022","unstructured":"Fayed EA, Gohar NA, Farrag AM, Ammar YA. Upregulation of BAX and caspase\u20103, as well as downregulation of Bcl\u20102 during treatment with indeno[1,2\u2010b]quinoxalin derivatives, mediated apoptosis in human \u2026. Arch Pharm. 2022;355(5):2100454.","journal-title":"Arch Pharm"},{"key":"e_1_3_4_107_1","doi-asserted-by":"crossref","first-page":"108218","DOI":"10.1016\/j.bioorg.2025.108218","article-title":"Novel Pyrrolidine-bearing quinoxaline inhibitors of DNA Gyrase, RNA polymerase and spike glycoprotein","volume":"156","author":"Ebrahim MA","year":"2025","unstructured":"Ebrahim MA, Ramsis TM, Gohar NA, Metwally SA, Rushdi A, Fayed EA. Novel Pyrrolidine-bearing quinoxaline inhibitors of DNA Gyrase, RNA polymerase and spike glycoprotein. Bioorg Chem. 2025;156:108218.","journal-title":"Bioorg Chem"},{"key":"e_1_3_4_108_1","doi-asserted-by":"crossref","first-page":"132839","DOI":"10.1016\/j.molstruc.2022.132839","article-title":"Design, synthesis, in silico studies, in vivo and in vitro assessment of pyridones and thiazolidinones as anti-inflammatory, antipyretic and ulcerogenic hits","volume":"1260","author":"Fayed EA","year":"2022","unstructured":"Fayed EA, Al-Arab EME, Saleh AS, Bayoumi AH, Ammar YA. Design, synthesis, in silico studies, in vivo and in vitro assessment of pyridones and thiazolidinones as anti-inflammatory, antipyretic and ulcerogenic hits. J Mol Struct. 2022;1260:132839.","journal-title":"J Mol Struct"},{"issue":"1","key":"e_1_3_4_109_1","doi-asserted-by":"crossref","first-page":"2367128","DOI":"10.1080\/14756366.2024.2367128","article-title":"Fluorinated indeno-quinoxaline bearing thiazole moieties as hypoglycaemic agents targeting \u03b1-amylase, and \u03b1-glucosidase: synthesis, molecular docking, and ADMET studies","volume":"39","author":"Gohar NA","year":"2024","unstructured":"Gohar NA, Fayed EA, A. Ammar Y, A. Abu Ali O, Ragab A, Mahfoz AM, Abusaif MS. Fluorinated indeno-quinoxaline bearing thiazole moieties as hypoglycaemic agents targeting \u03b1-amylase, and \u03b1-glucosidase: synthesis, molecular docking, and ADMET studies. J Enzyme Inhib Med Chem. 2024;39(1):2367128.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"2","key":"e_1_3_4_110_1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00044-022-03004-8","article-title":"Novel fluorinated pyrazole-based heterocycles scaffold: cytotoxicity, in silico studies and molecular modelling targeting double mutant EGFR L858R\/T790M as antiproliferative and apoptotic agents","volume":"32","author":"Fayed EA","year":"2023","unstructured":"Fayed EA, Gohar NA, Bayoumi AH, Ammar YA. Novel fluorinated pyrazole-based heterocycles scaffold: cytotoxicity, in silico studies and molecular modelling targeting double mutant EGFR L858R\/T790M as antiproliferative and apoptotic agents. Med Chem Res. 2023;32(2):369\u2013388.","journal-title":"Med Chem Res"},{"key":"e_1_3_4_111_1","doi-asserted-by":"crossref","first-page":"108023","DOI":"10.1016\/j.bioorg.2024.108023","article-title":"Exploring a novel thiazole derivatives hybrid with fluorinated-indenoquinoxaline as dual inhibitors targeting VEGFR2\/AKT and apoptosis inducers against hepatocellular carcinoma with docking simulation","volume":"154","author":"Abusaif MS","year":"2025","unstructured":"Abusaif MS, Ragab A, Fayed EA, Ammar YA, Gowifel AMH, Hassanin SO, Ahmed GE, Gohar NA. Exploring a novel thiazole derivatives hybrid with fluorinated-indenoquinoxaline as dual inhibitors targeting VEGFR2\/AKT and apoptosis inducers against hepatocellular carcinoma with docking simulation. Bioorg Chem. 2025;154:108023.","journal-title":"Bioorg Chem"}],"container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14756366.2025.2598741","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:23:45Z","timestamp":1767374625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14756366.2025.2598741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":110,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/14756366.2025.2598741"],"URL":"https:\/\/doi.org\/10.1080\/14756366.2025.2598741","relation":{},"ISSN":["1475-6366","1475-6374"],"issn-type":[{"value":"1475-6366","type":"print"},{"value":"1475-6374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-07-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2598741"}}